DIA 2025 Global Annual Meeting

Component Type: Forum

Start your day with a powerful and inspiring session that brings together visionary leaders, groundbreaking science, and real-world patient experiences. DIA President and CEO Marwan Fathallah sets the stage, followed by a moving personal story from Jimi Olaghere, who shares his extraordinary journey from a sickle cell diagnosis to conquering Mt. Kilimanjaro. Dive into the future of innovative treatments with a keynote on Type 1 Diabetes breakthroughs by renowned researcher Douglas Melton. The session concludes with a dynamic multi-stakeholder panel, where top regulators, researchers, and industry leaders explore how global collaboration can accelerate patient-centered innovation and derisk product development.

Learning Objectives

Describe how patient experiences and personal journeys can inform and inspire innovative approaches to drug development and healthcare solutions; Analyze the scientific and regulatory challenges associated with developing innovative treatments for chronic and rare diseases, such as Type 1 Diabetes and Sickle Cell Anemia; Identify collaborative strategies that enable multi-stakeholder partnerships to derisk medical product development and accelerate patient access to innovative therapies.

Chair

Marwan Fathallah, MBA, MSc

Speaker

The Patient Experience
Jimi Olaghere

The Future of Innovative Treatments
Doug Melton, PhD